SCHEMBL30070286

SCHEMBL30070286

N=C(N)NCCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 1/20 0.41
▸ TFPI P10646 1/20 0.39
▸ TLR2 O60603 2/20 0.38
▸ NMT2 O60551 2/20 0.38
▸ NMT1 P30419 2/20 0.38
▸ NFE2L2 Q16236 1/20 0.37
▸ NPY4R P50391 3/20 0.37
▸ NPY1R P25929 2/20 0.37
▸ NPY2R P49146 2/20 0.37
▸ NPY5R Q15761 2/20 0.37
▸ IL23R Q5VWK5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30070332 1.00 FOLH1 (0.41) FOLH1TFPITLR2NMT2NMT1
SCHEMBL30070336 0.99 FOLH1 (0.42) FOLH1TFPINMT2NMT1NPY4R
SCHEMBL30070426 0.99 FOLH1 (0.42) FOLH1TFPINMT2NMT1NPY4R
SCHEMBL30070283 0.96 NPY4R (0.37) TLR2NMT2NMT1NFE2L2NPY4R
SCHEMBL30070292 0.96 NPY4R (0.37) TLR2NMT2NMT1NFE2L2NPY4R
SCHEMBL30070334 0.95 NPY4R (0.37) FOLH1NPY4RNPY1RNPY2RNPY5R
SCHEMBL30070279 0.95 NPY4R (0.38) TLR2NMT2NMT1NPY4RNPY1R
SCHEMBL30070254 0.95 NPY4R (0.38) TLR2NMT2NMT1NPY4RNPY1R
SCHEMBL30070230 0.95 NPY4R (0.38) FOLH1NPY4RNPY1RNPY2RNPY5R
SCHEMBL30070216 0.92 FOLH1 (0.48) FOLH1TLR2NMT2NMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110172081-B Polypeptide molecule derivative with mineralization function for biomedical tissue engineering and application thereof 南京九阵维医疗科技有限公司 2022-12-13 — — CN disclosed
Send feedback